Analyst Recommendations

4.10 -0.10(-2.38%)06/28/2024
Zentalis Pharmaceuticals LLC (ZNTL)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy5
Equal-Weight2
Neutral2
Outperform1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades